Miro1 improves the exogenous engraftment efficiency and therapeutic potential of mitochondria transfer using Wharton's jelly mesenchymal stem cells
Mitochondrion · 2024-05 · 76 · 101856
DOI: 10.1016/j.mito.2024.101856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mitochondrion, 2024-05. Verfasst von Yu-Han Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833401, Taiwan. Electronic address: cgmhlinyh202@cg…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Mitochondria, rho GTP-Binding Proteins, Wharton Jelly. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Chang Gung Memorial Hospital Kaohsiung Branch, National Science and Technology Council, Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Mitochondria are important for maintaining cellular energy metabolism and regulating cellular senescence. Mitochondrial DNA (mtDNA) encodes subunits of the OXPHOS complexes which are essential for cellular respiration and energy production. Meanwhile, mtDNA variants have been associated with the pathogenesis of neurodegenerative diseases, including MELAS, for which no effective treatment has been developed. To alleviate the pathological conditions involved in mitochondrial disorders, mitochondria transfer therapy has shown promise. Wharton's jelly mesenchymal stem cells (WJMSCs) have been identified as suitable mitochondria donors for mitochondria-defective cells, wherein mitochondrial functions can be rescued. Miro1 participates in mitochondria trafficking by anchoring mitochondria to microtubules. In this study, we identified Miro1 over-expression as a factor that could help to enhance the efficiency of mitochondrial delivery. More specifically, we reveal that Miro1 over-expressed WJMSCs significantly improved intercellular communications, cell proliferation rates, and mitochondrial membrane potential, while restoring mitochondrial bioenergetics in mitochondria-defective fibroblasts. Furthermore, Miro1 over-expressed WJMSCs decreased rates of induced apoptosis and ROS production in MELAS fibroblasts; although, Miro1 over-expression did not rescue mtDNA mutation ratios nor mitochondrial biogenesis. This study presents a potentially novel therapeutic strategy for treating mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), and other diseases associated with dysfunctional mitochondria, while the pathophysiological relevance of our results should be further verified by animal models and clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833401, Taiwan. Electronic address: cgmhlinyh202@cgmh.org.tw.
- Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833401, Taiwan; Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Me…
- Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833401, Taiwan. Electronic address: a0977290491@cgmh.org.tw.
- Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833401, Taiwan; Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of…
- Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833401, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Medical Re…
- Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833401, Taiwan; Department of Metabolism, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medici…
Förderung
- Chang Gung Memorial Hospital Kaohsiung Branch
- National Science and Technology Council
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Lin, Y. H., Lin, K. L., Wang, X. W., Lee, J. J., Wang, F. S., Wang, P. W., Lan, M. Y., Liou, C. W., & Lin, T. K. (2024). Miro1 improves the exogenous engraftment efficiency and therapeutic potential of mitochondria transfer using Wharton's jelly mesenchymal stem cells. Mitochondrion, 76, 101856. https://doi.org/10.1016/j.mito.2024.101856
Vancouver
Lin YH, Lin KL, Wang XW, Lee JJ, Wang FS, Wang PW, et al. Miro1 improves the exogenous engraftment efficiency and therapeutic potential of mitochondria transfer using Wharton's jelly mesenchymal stem cells. Mitochondrion. 2024;76:101856. doi:10.1016/j.mito.2024.101856
BibTeX
@article{Lin2024,
author = {Lin, Yu-Han and Lin, Kai-Lieh and Wang, Xiao-Wen and Lee, Jong-Jer and Wang, Feng-Sheng and Wang, Pei-Wen and Lan, Min-Yu and Liou, Chia-Wei and Lin, Tsu-Kung},
title = {Miro1 improves the exogenous engraftment efficiency and therapeutic potential of mitochondria transfer using Wharton's jelly mesenchymal stem cells},
journal = {Mitochondrion},
year = {2024},
volume = {76},
pages = {101856},
doi = {10.1016/j.mito.2024.101856}
}
EUVIMED